MNC如罗氏、安进、默沙东、阿斯利康等,都有GLP-1产品正在开发中。 参考文章: 1、Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes;endpoints 2、Lilly's oral GLP-1 drug delivers Ozempic-like efficacy in phase 3 diabetes trial;fiercebiotech ...
MNC如罗氏、安进、默沙东、阿斯利康等,都有GLP-1产品正在开发中。 参考文章: 1、Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes;endpoints 2、Lilly's oral GLP-1 drug delivers Ozempic-like efficacy in phase 3 diabetes trial;fiercebiotech 3、Lilly Skyrockets on ‘...
1.Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug.,Barron's 2.Amgen shares soar as executives outline obesity drug push;BioPharma Dive 3.Chasing Novo and Lilly: The obesity drugs that...
[1] GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years[J]. New England journal of medicine, 2017, 377(1): 13-27.[2] 中国居民营养与慢性病状况报告2020 [3] Müller T D, Blüher M, Tschöp M H, et al. Anti-obesity drug discovery:...
资料来源：Drug Des Devel Ther. Lijing Wang，《Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP》，X技术，国知局，华福研究所 替尔泊肽结构设计基于GLP-1、GIP及艾塞那肽的部分结构、以及增加的特有氨基酸（其中Aib是非天然氨基酸），合成...
康日百奥Bioworkshops已成功交付了超过200批次的成品(Drug Product, DP)的cGMP无菌灌装。康日百奥Bioworkshops无菌灌装服务包括：无菌预充针、卡式瓶灌装服务 可实现0.2mL-5.0mL不同制剂规格高效切换及连续生产；引入了智能化的无菌预灌封系统，借助2个超洁净无菌机器人手臂，完全实现了灌装的高精度，提供了稳定的无菌...
Chinese pharma to ride on the global GLP-1 drugs bonanza;Nomura Riding GLP-1 wave, Novo Nordisk lays out $560M to boost drug production in China;Fierce Pharma 中国GLP-1类“减肥”新药3期临床试验一览;医药观澜
Renaissance in Peptide Drug Discovery: The Third Wave. https://books.rsc.org/books/edited-volume/661/chapter/358216/Renaissance-in-Peptide-Drug-Discovery-The-Third. Trends in peptide drug discovery - Nature. https://www.nature.com/articles/s41573-020-00135-8.pdf. ...
[1] How one scientist’s determination made Novo Nordisk an obesity-drug powerhouse. Retrieved October 24, 2023, from https://www.statnews.com/2023/10/17/lotte-knudsen-novo-nordisk-obesity-drug-liraglutide-ozempic-wegovy/ [2] Parks M, Rosebraugh C. Weighing risks and benefits of liraglutide...
show. Reuters. 11. 07. 2023.9.O’Connor, A. M. The Surprising Truth About Obesity Drug Dropouts. HealthCentral. 10. 12. 2023.*声明：本文仅是介绍医药疾病领域研究进展或简述研究概况或分享医药相关讯息，并非也不会进行治疗或诊断方案推荐，也不对相关投资构成任何建议。内容如有疏漏，欢迎沟通指出！